FDA recommends Pfizer COVID booster shot for people 65 and older, high-risk groups

 The US Food and Drug Administration (FDA) has recommended Pfizer's COVID booster doses for people 65 and older or at high risk of severe illness from the virus.
However, the agency rejected third shots for the general population.
The recommendation was made after a panel voted 16 to 2 against distributing the vaccines to Americans 16 and older.
The panel unanimously embraced an alternative plan to give boosters to older Americans and those at a high risk of suffering from severe illness if they get the virus.
That included people with diabetes, heart disease, obesity and other so-called comorbidities.
Administration of the Pfizer vaccine has been suspended in Jamaica due to a supply shortage.
The latest RJRGLEANER Don Anderson poll has shown that Pfizer is the preferred vaccine among those Jamaicans who are particular about the brand of COVID-19 vaccine they receive.

comments powered by Disqus
Most Popular
Police say they prevented potential mass...
Police searching home of religious leader...
Another St. Thomas child missing